Rhabdomyosarcoma of the urinary tract is very rare among young adult and the survival has improved significantly. The challenge of such location is to ensure better functional outcomes like continence and sexuality without compromising the overall survival. Throughout this case, we bring new insights into the conservative management of prostatic sarcoma and we focus on the role of radio-chemotherapy for disease
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573834 | PMC |
| http://dx.doi.org/10.1016/j.eucr.2020.101328 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Long-Term Urinary and Sexual Outcomes in Pediatric Genitourinary Rhabdomyosarcoma Survivors: A Qualitative Study.
J Urol
December 2024
Department of Urology, Boston Children's Hospital, Boston, Massachusetts.
Purpose: Genitourinary rhabdomyosarcoma (GU-RMS) often requires multimodal therapy treatment including radiation, chemotherapy, and radical surgery for disease control. The long-term effects of the disease and associated treatments are unclear. We sought to investigate the long-term genitourinary quality of life for adult survivors of pediatric GU-RMS.
View Article and Find Full Text PDFAnalysis of Genitourinary Rhabdomyosarcoma in Phase 3 clinical trials.
World J Urol
December 2024
Department of Urology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 668, Rochester, NY, 14642, USA.
Purpose: Pediatric Rhabdomyosarcoma (RMS) is a morbid and often lethal condition characterized by a paucity of clinical data. Beyond a detailed risk categorization system, it is unclear if genitourinary (GU) sites (bladder/prostate, paratesticular, female organs) have outcomes distinct from non-GU sites. This study pools primary data from phase-3 clinical trials involving pediatric RMS to evaluate this question.
View Article and Find Full Text PDFEmbryonal rhabdomyosarcoma of prostate combined with prostatic abscess in an adult patient: a case report and literature review.
Transl Androl Urol
September 2024
Division of Urology, Department of Surgery, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Background: Embryonal rhabdomyosarcoma (ERMS) of the prostate is a rare and aggressive malignant tumor in adults with a poor prognosis in general. The main presenting symptoms are dysuria and acute urinary retention. Prostate ERMS is easily misdiagnosed, which leads to delays in treatment.
View Article and Find Full Text PDFSpindle Cell Rhabdomyosarcoma of the Prostate With ZFP64::NCOA2 Fusion.
Genes Chromosomes Cancer
September 2024
Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Adult Prostate Sarcoma: Demographics, Treatment Patterns, and Survival.
Ann Surg Oncol
December 2024
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
Article Synopsis
- This study analyzed the clinicopathologic characteristics and treatment patterns of adult prostate sarcoma patients using data from the Surveillance, Epidemiology, and End Results database between 2004 and 2020.
- Among 125 patients, the most common subtype was leiomyosarcoma (36%), with rhabdomyosarcoma (14%) being more likely to present at a metastatic stage compared to other types.
- The overall median survival was 27 months, with treatment approaches differing significantly based on the subtype; metastatic disease was linked to higher mortality rates, while stromal sarcoma had a lower overall mortality risk.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!